Literature DB >> 1371792

Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes.

T Hasunuma1, H Tsubota, M Watanabe, Z W Chen, C I Lord, L C Burkly, J F Daley, N L Letvin.   

Abstract

Cell surface-expressed CD4 binds to the envelope glycoprotein of HIV-1 and mediates syncytia formation through interacting with membrane expressed HIV-1 gp120. Further possible roles of the CD4 molecule in the process of cell infection by HIV-1 remain poorly understood. In our study we describe two mAb that recognize the V3/V4 domain of the CD4 molecule. Although these mAb do not inhibit gp120-CD4 binding or HIV-1-induced syncytia formation, they inhibit HIV-1 infection of human PBL. These findings suggest that discrete, definable domains of the CD4 molecule may be involved in interactions after HIV-1 envelope binding that lead to virus entry into the cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371792

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity.

Authors:  M Watanabe; J E Boyson; C I Lord; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.

Authors:  S Moir; J Perreault; L Poulin
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1.

Authors:  J H Simon; P Stumbles; N Signoret; C Somoza; M Puklavec; Q J Sattentau; A N Barclay; W James
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 4.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

5.  Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.

Authors:  P Bérubé; B Barbeau; R Cantin; R P Sékaly; M Tremblay
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.

Authors:  Y Tani; E Donoghue; S Sharpe; E Boone; H C Lane; S Zolla-Pazner; D I Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.

Authors:  R E Bachelder; J Bilancieri; W Lin; N L Letvin
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells.

Authors:  M Benkirane; K T Jeang; C Devaux
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

10.  An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells.

Authors:  M Benkirane; P Corbeau; V Housset; C Devaux
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.